Independent cancer second opinion for Australian patients
For patients in every state and territory. Kim reviews Signatera, Guardant360 and comprehensive genomic profiling reports, and searches the ANZCTR and international registries for trials that fit your results.
What Kim reviews
- Pathology and tumor profiling (NGS) reports, including FoundationOne, Caris, Tempus and Guardant360
- Signatera and other ctDNA results
- Clinical trials that fit your molecular profile, locally and internationally
- Written questions and evidence your oncologist can act on
Price and scheduling
Every engagement starts with a free 15-minute call. No records or payment needed, and no obligation. The Clarity Report is USD $2,000 (about A$3,050). Active Case Management: $4,500 / month; Concierge Advisory: $7,500 / month.
Video calls in AEST / AEDT. Paid receipts are suitable for Bupa, Medibank, HCF, and nib reimbursement where policies allow.
All fees are in US dollars and payable online by card. Calls are scheduled to fit your time zone. Records in languages other than English may require translation before review.
Calls are with Kim Lockheimer, PhD, DFM, Chief Scientific Officer. Prices in local currency: /au/pricing.
Advisory only: diagnosis and treatment stay with your treating oncologist.
Guides for patients
- Getting a private cancer second opinion in Australia
- Signatera test in Australia
- Guardant360 in Australia
- Melanoma second opinion in Australia